Back to Search Start Over

Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer.

Details

Language :
English
ISSN :
09594973
Volume :
23
Issue :
6
Database :
Complementary Index
Journal :
Anti-Cancer Drugs
Publication Type :
Academic Journal
Accession number :
109486621
Full Text :
https://doi.org/10.1097/CAD.0b013e328352ff1d